Celltrion Strikes $278m Deal With Takeda

Korean Firm Expands In APAC, Small Molecules Via Takeda Asset Buy

 
• By Ian Haydock and Jung Won Shin

Celltrion has bought a portfolio of selected products in the Asia-Pacific region from Takeda, marking a foray into small-molecule drugs.

Celltrion Headquarters
Celltrion Expands In Asia With Takeda Deal

More from Deals

More from Business